Investment Instruments

Bright Heath's market debut caps a string of public listings of new health care businesses, including insurers and primary-care companies.

Michael Finke and David Blanchett point out big flaws in the study but say it raises a few valid points.

In recent months, the industry has seen six megadeals valued at $5 billion or more.

In an interview in March, the "Contrarian's Contrarian" delivered his prescription for investing amid impending disaster, as he sees it. It's June now -- is he right?

Within the benefits space, annuities are drawing increasing interest, although some misconceptions remain.

Social media creates investing interest, but parents still are influential.